Search details
1.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Article
in English
| MEDLINE | ID: mdl-34081848
2.
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(1): 77-90, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36493792
3.
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Lancet Oncol
; 24(8): e331-e343, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37541279
4.
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
Int J Cancer
; 153(4): 803-814, 2023 08 15.
Article
in English
| MEDLINE | ID: mdl-36971103
5.
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer.
Curr Treat Options Oncol
; 24(11): 1633-1650, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37878202
6.
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.
Lancet Oncol
; 23(11): 1398-1408, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36265504
7.
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
Lancet Oncol
; 23(1): e21-e31, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34973228
8.
Comparison of claudin-3 and claudin-4 expression in bilateral and unilateral breast cancer.
Neoplasma
; 68(2): 283-289, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33147053
9.
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
N Engl J Med
; 377(6): 523-533, 2017 08 10.
Article
in English
| MEDLINE | ID: mdl-28578601
10.
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98.
Psychooncology
; 23(2): 173-82, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24038775
11.
Are bilateral breast cancers and breast cancers coexisting with ovarian cancer different from solitary tumors? A pair-matched immunohistochemical analysis aimed at intrinsic tumor phenotype.
Pathol Int
; 64(10): 508-17, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25296577
12.
Breast cancer highlights from 2023: Knowledge to guide practice and future research.
Breast
; 74: 103674, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38340683
13.
Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes.
Biomedicines
; 12(4)2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38672117
14.
Reporting on invasive lobular breast cancer in clinical trials: a systematic review.
NPJ Breast Cancer
; 10(1): 23, 2024 Mar 20.
Article
in English
| MEDLINE | ID: mdl-38509112
15.
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.
J Clin Oncol
; 42(9): 987-993, 2024 Mar 20.
Article
in English
| MEDLINE | ID: mdl-38194616
16.
Are All Societies Ready for Digital Tools? Feasibility Study on the Use of Mobile Application in Polish Early Breast Cancer Patients Treated with Perioperative Chemotherapy.
Healthcare (Basel)
; 11(14)2023 Jul 24.
Article
in English
| MEDLINE | ID: mdl-37510555
17.
Improved Characterization of Circulating Tumor Cells and Cancer-Associated Fibroblasts in One-Tube Assay in Breast Cancer Patients Using Imaging Flow Cytometry.
Cancers (Basel)
; 15(16)2023 Aug 18.
Article
in English
| MEDLINE | ID: mdl-37627197
18.
OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer.
Eur J Cancer
; 184: 39-47, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36893711
19.
Mobile applications for early breast cancer chemotherapy-related symptoms reporting and management: A scoping review.
Cancer Treat Rev
; 105: 102364, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35231871
20.
Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer.
Breast
; 66: 145-156, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36279803